| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/11/2009 | WO2009109071A1 Imidazopyridine compounds |
| 09/11/2009 | WO2009090624A3 Chitosan gel for dermatological use, production method therefor and use of same |
| 09/11/2009 | WO2009088891A8 Screening method for selected amino lipid-containing compositions |
| 09/11/2009 | WO2009087682A3 Stabilized injectable formulation of pregabalin |
| 09/11/2009 | WO2009087678A3 Nanodispersion |
| 09/11/2009 | WO2009087148A3 Analgesic apatitic calcium-phosphate cement |
| 09/11/2009 | WO2009085302A3 Method and multilayered device for controlled topical delivery of therapeutic agents to the skin |
| 09/11/2009 | WO2009080762A3 Pharmaceutical composition |
| 09/11/2009 | WO2009071219A3 Oral dispersable tablet |
| 09/11/2009 | WO2009047826A3 Pharmaceutical composition comprising sucralphate and mesalazine |
| 09/11/2009 | WO2009038701A3 Formulation containing cyclin-dependent kinase inhibiting compound and method of treating tumors using the same |
| 09/11/2009 | WO2009019571A3 Method of dissolving essential oils in water |
| 09/11/2009 | WO2009001697A3 Microspheres having core/shell structure |
| 09/11/2009 | WO2008127366A3 A device and method for treating osteolysis using a drug depot to deliver an anti-inflammatory agent |
| 09/11/2009 | WO2008120085A3 Angiogenic composition |
| 09/11/2009 | WO2007030902A3 Improved pharmaceutical composition containing artichoke extract, and process for its production |
| 09/11/2009 | CA2717737A1 Hand sanitizing patch |
| 09/11/2009 | CA2717736A1 Modulation of srpx2-mediated angiogenesis |
| 09/11/2009 | CA2717481A1 Methods to inhibit tumor cell growth by using proton pump inhibitors |
| 09/11/2009 | CA2717456A1 Modified release pharmaceutical compositions comprising mycophenolate and processes thereof |
| 09/11/2009 | CA2717259A1 Controlled release drug delivery systems and pharmaceutical compositions formed therewith |
| 09/11/2009 | CA2717201A1 Macrolide compositions having improved taste and stability |
| 09/11/2009 | CA2717182A1 Process for preparing a pharmaceutical composition with anti-inflammatory and analgesic activity for administration via a patch for external use, and composition thus obtained |
| 09/11/2009 | CA2716838A1 Ccr5 antagonists as prophylactics for preventing hiv infection and methods of inhibiting transmission of same |
| 09/11/2009 | CA2716130A1 Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor |
| 09/11/2009 | CA2715832A1 Topotecan ready to use solutions |
| 09/11/2009 | CA2715685A1 Pharmaceutical solutions, process of preparation and therapeutic uses |
| 09/10/2009 | US20090227989 Multiple reservoir implantable drug infusion device and method |
| 09/10/2009 | US20090227930 Hygiene materials and absorbents |
| 09/10/2009 | US20090227802 Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof |
| 09/10/2009 | US20090227768 Anti-Allergic Complex Molecules |
| 09/10/2009 | US20090227688 Admixture of carotenoids having provitamin a activity and carotenoids devoid of provitamin a activity for treating aging symptoms |
| 09/10/2009 | US20090227668 Topical application of ivermectin for the treatment of dermatological conditions/afflictions |
| 09/10/2009 | US20090227536 Compositions comprising pectin and ascorbic acid |
| 09/10/2009 | US20090227510 Induction of tumor immunity by variants of folate binding protein |
| 09/10/2009 | US20090226532 biodegradable block copolymer constructed from poly(ethylene glycol)-terephthalate and poly(butylene terephthalate), a preferred therapeutic compound is alpha-interferons; sustained release; in-situ gelation; alpha interferons are released in monomeric, non-aggregated form |
| 09/10/2009 | US20090226531 Methods and composition for intraocular delivery of therapeutic sirna |
| 09/10/2009 | US20090226530 Powdered protein compositions and methods of making same |
| 09/10/2009 | US20090226529 Granulated composition |
| 09/10/2009 | US20090226528 Encapsulated nanoparticles for nucleic acid delivery |
| 09/10/2009 | US20090226527 Particulate-stabilized injectable pharmacutical compositions of posaconazole |
| 09/10/2009 | US20090226526 Nanoparticles of a heterocrystal mineral for use as a medicament and method of producing the same |
| 09/10/2009 | US20090226525 Self-assembling nanoparticle drug delivery system |
| 09/10/2009 | US20090226524 Stable active compound complex of salts of o-acetylsalicylic acid with basic amino acids and glycine |
| 09/10/2009 | US20090226523 Demineralized bone matrix compositions and methods |
| 09/10/2009 | US20090226522 Process to minimize polymorphism |
| 09/10/2009 | US20090226521 Active nanoparticles and method of using |
| 09/10/2009 | US20090226520 Medical composition employing nanostructures |
| 09/10/2009 | US20090226519 Hydrogel bioscaffoldings and biomedical device coatings |
| 09/10/2009 | US20090226518 (monitoring only) combinations of hmg-coa reductase inhibitors and nicotinic acid compounds and methods for treating hypelipidemia once a day at night |
| 09/10/2009 | US20090226517 Pharmaceutical formulations comprising duloxetine |
| 09/10/2009 | US20090226516 Sartan compositions |
| 09/10/2009 | US20090226515 Statin compositions |
| 09/10/2009 | US20090226514 Compressed |
| 09/10/2009 | US20090226513 Na/K-ATpase Ligand |
| 09/10/2009 | US20090226512 Methods and Compositions for Oral Delivery of FTS |
| 09/10/2009 | US20090226511 Novel pharmaceutical formulation in the form of cellulose capsules suitable for benzimidazole derivatives |
| 09/10/2009 | US20090226510 Pharmaceutical compositions of atorvastatin |
| 09/10/2009 | US20090226509 Composition for treatment of inflammatory disorders |
| 09/10/2009 | US20090226508 Methods And Materials For Immunization Against Cancer |
| 09/10/2009 | US20090226507 Hydroxide-releasing agents as skin permeation enhancers |
| 09/10/2009 | US20090226506 Patterned Gradient Wound Dressing and Methods of Using Same to Promote Wound Healing |
| 09/10/2009 | US20090226503 Adhesion inhibiting material for vertebral/spinal operation |
| 09/10/2009 | US20090226499 Biocompatible materials containing stable complexes of tsg-6 and hyaluronan and method of using same |
| 09/10/2009 | US20090226498 Moisturizing hand sanitizer |
| 09/10/2009 | US20090226495 Nanodiamond enhanced efficacy |
| 09/10/2009 | US20090226493 Agglomerates of Sucralose and Polyols, and their Use in Chewing Gums |
| 09/10/2009 | US20090226492 Use of an activated zeolite as a pharmaceutical agent for reducing toxic substances |
| 09/10/2009 | US20090226491 Water-based delivery systems |
| 09/10/2009 | US20090226485 Vaccination of pigs against disease by administering a first recombinant porcine adenovirus vector stably expressing a heterologous nucleotide sequence encoding the antigenic determinant of the disease, preferably Hog Cholera Virus or Pseudorabies virus |
| 09/10/2009 | US20090226484 Immunogenic LHRH compositions and methods relating thereto |
| 09/10/2009 | US20090226407 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 09/10/2009 | US20090226392 Phosphate-Binding Polymers for Oral Administration |
| 09/10/2009 | US20090226383 Chewing Gum Having Improved Release of Chewing Gum Ingredients |
| 09/10/2009 | US20090226381 Method and Composition for Reducing the Drying Time of Hair |
| 09/10/2009 | US20090226380 Topical Skin Treating Compositions |
| 09/10/2009 | DE102008012015A1 Verbesserte Isomalt-haltige Komprimate und Verfahren zu ihrer Herstellung Improved isomalt-containing compressed and processes for their preparation |
| 09/09/2009 | EP2098503A1 5-[(2r)-[2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2-methoxybenzenesulfonamide |
| 09/09/2009 | EP2098250A1 Orally disintegrating solid preparation |
| 09/09/2009 | EP2098249A1 Nicorandil carriers with enhanced stability |
| 09/09/2009 | EP2098248A1 Combination of anticholinergics, glucocorticoids and beta2-agonists for the treatment of inflammatory diseases |
| 09/09/2009 | EP2098243A1 G-CSF liquid formulation |
| 09/09/2009 | EP2098235A1 Method for prevention of discoloration with time of donepezil-containing skin adhesive preparation |
| 09/09/2009 | EP2098234A1 Skin adhesive preparation comprising stabilized donepezil |
| 09/09/2009 | EP2098233A1 Skin adhesive preparation comprising stabilized donepezil |
| 09/09/2009 | EP2098232A1 Percutaneous absorption preparation |
| 09/09/2009 | EP2098230A1 Use of cytoskeletal inhibitors in crystalline form for the inhibition or prevention of restenosis |
| 09/09/2009 | EP2098225A2 Taste masking system for non-plasticizing drugs |
| 09/09/2009 | EP2098224A1 Rapidly disintegrating gelatinous coated tablets |
| 09/09/2009 | EP2098223A1 Compressed solid dosage form |
| 09/09/2009 | EP2098222A1 Physiologically active substance-containing granular composition and method of producing the same |
| 09/09/2009 | EP2098221A1 Composition for iontophoresis for delivery through hair pore |
| 09/09/2009 | EP2098220A2 Fluid device and fluid device assembly |
| 09/09/2009 | EP2098219A1 Macrolide compositions having improved taste and stability |
| 09/09/2009 | EP2097572A2 Textile and/or fiber processing method using an active ingredient composed of nanoparticles |
| 09/09/2009 | EP2097107A2 Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution |
| 09/09/2009 | EP2097086A2 Contact lens compositions |
| 09/09/2009 | EP2097078A1 Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer |
| 09/09/2009 | EP2097077A1 Benzoyl peroxyde comprising compositions, at least one naphtoic acid derivative and at least one compound of polyurethane polymer-type or derivatives thereof, and their use |
| 09/09/2009 | EP2097074A2 Topical pharmaceutical composition |